Development and characterization of an open tubular column containing immobilized P-glycoprotein for rapid on-line screening for P-glycoprotein substrates

被引:46
|
作者
Moaddel, R
Bullock, PL
Wainer, IW [1 ]
机构
[1] NIA, Bioanalyt & Drug Discovery Unit, Intramural Res Program, Lab Clin Investigat,Gerontol Res Ctr, Baltimore, MD 21224 USA
[2] Purdue Pharma LP, Discovery Support, Ardsley, NY USA
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2004年 / 799卷 / 02期
关键词
substrates; ABC transporters; screening; P-glycoprotein;
D O I
10.1016/j.jchromb.2003.10.054
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Cellular membranes from a cell line expressing P-glycoprotein (Pgp(+)) and from a cell line that does not express Pgp (Pgp(-)) were immobilized on the surface of glass capillaries (25 cm x 100 mum i.d.) by non-covalent interactions using the avidin-biotin coupling system to create two open tubular columns, Pgp(+)-OT and Pgp(-)-OT. Frontal displacement chromatography on the Pgp(+)-OT demonstrated that the immobilized Pgp retained its ability to specifically bind the known Pgp substrates vinblastin and ketoconazole. The calculated affinities, expressed as K-d, for vinblastin and ketoconazole were 97 nM and 12.1 muM, which were comparable with previously reported Kd values of 37 nM and 8.6 muM, respectively. The results confirm that the Pgp(+)-OT can be used to quantitatively estimate binding affinities for the Pgp. Frontal displacement chromatography on the Pgp(-)-OT demonstrated that the immobilized membranes retained the ability to bind some Pgp substrates, but that the binding was not due to specific binding to Pgp. A cohort of compounds containing high affinity Pgp substrates (vinblastin, prazosin) and moderate-low affinity Pgp substrates (doxorubicin, verapamil, ketoconazole) and a non-substrate (nicotine) were chromatographed on the Pgp(+)-OT and Pgp(-)-OT using fast frontal analysis and mass spectrometric detection. The results demonstrated that when the retention on the Pgp(+)-OT was corrected by subtraction of the retention on the Pgp(-)-OT, the test compounds could be accurately sorted into high, moderate-low and non-substrate categories. The data from the study indicates that a single 30-min parallel chromatographic experiment can be used to rank a compound based upon its relative affinity for the immobilized Pgp. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:255 / 263
页数:9
相关论文
共 50 条
  • [31] Future perspectives for the development of P-glycoprotein modulators
    Sandor, V
    Fojo, T
    Bates, SE
    DRUG RESISTANCE UPDATES, 1998, 1 (03) : 190 - 200
  • [32] Characterization of phosphine complexes of technetium(III) as transport substrates of the multidrug resistance P-glycoprotein and functional markers of P-glycoprotein at the blood-brain barrier
    Luker, GD
    Rao, VV
    Crankshaw, CL
    Dahlheimer, J
    PiwnicaWorms, D
    BIOCHEMISTRY, 1997, 36 (46) : 14218 - 14227
  • [33] Rapid assessment of P-glycoprotein inhibition and induction in vitro
    Perloff, MD
    Störmer, E
    von Moltke, LL
    Greenblatt, DJ
    PHARMACEUTICAL RESEARCH, 2003, 20 (08) : 1177 - 1183
  • [34] Rapid Assessment of P-Glycoprotein Inhibition and Induction in Vitro
    Michael D. Perloff
    Elke Störmer
    Lisa L. von Moltke
    David J. Greenblatt
    Pharmaceutical Research, 2003, 20 : 1177 - 1183
  • [35] Development of Simplified in Vitro P-Glycoprotein Substrate Assay and in Silico Prediction Models To Evaluate Transport Potential of P-Glycoprotein
    Ohashi, Rikiya
    Watanabe, Reiko
    Esaki, Tsuyoshi
    Taniguchi, Tomomi
    Torimoto-Katori, Nao
    Watanabe, Tomoko
    Ogasawara, Yuko
    Takahashi, Tsuyoshi
    Tsukimoto, Mikiko
    Mizuguchi, Kenji
    MOLECULAR PHARMACEUTICS, 2019, 16 (05) : 1851 - 1863
  • [36] Analysis of structure-activity relationships of P-glycoprotein mediators for development of a new P-glycoprotein inhibitor: Pyronaridine.
    Yang, CZ
    Qi, J
    Wang, SB
    Peng, H
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U481 - U481
  • [37] Impact of P-glycoprotein-mediated intestinal efflux kinetics on oral Bioavailability of P-glycoprotein substrates
    Kwon, Hyojong
    Lionberger, Robert A.
    Yu, Lawrence X.
    MOLECULAR PHARMACEUTICS, 2004, 1 (06) : 455 - 465
  • [38] Structure-activity relationship of P-glycoprotein substrates and modifiers
    Seelig, A
    Landwojtowicz, E
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2000, 12 (01) : 31 - 40
  • [39] Several major antiepileptic drugs are substrates for human P-glycoprotein
    Luna-Tortos, Carlos
    Fedrowitz, Maren
    Loescher, Wolfgang
    NEUROPHARMACOLOGY, 2008, 55 (08) : 1364 - 1375
  • [40] Several major antiepileptic drugs are substrates for human P-glycoprotein
    Luna, Tortos C.
    Fedrowitz, M.
    Loescher, W.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2008, 377 : 11 - 11